Eularis staff routinely write columns and thought-leadership articles for other publications including EyeforPharma and PharmaPhorum.
Most pharma companies have invested something, if not a significant amount, in some kind of artificial intelligence (AI) initiative. However, not all companies are getting the returns they
In part 1 (click to access part 1) of this article I examined human collaboration, marketing personalization, AI becoming creative, and AI running within medical devices. In part 2 we examine some
The use of AI in healthcare has increased considerably in recent years due to the more widespread availability of big data. However, despite significant investment, most have yet to realize its full